Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 15;125(24):4452-4461.
doi: 10.1002/cncr.32495. Epub 2019 Sep 10.

Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity research

Michael Behring  1 , Kevin Hale  1 , Bunyamin Ozaydin  2 , William E Grizzle  1   3 , Stephen O Sodeke  4 , Upender Manne  1   3
Affiliations

Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity research

Michael Behring et al. Cancer. .

Abstract

Background: Although general trends in cancer outcomes are improving, racial/ethnic disparities in patient outcomes continue to widen, suggesting disparity-related shortcomings in cancer research designs.

Methods: Using convenience sampling, a total of 24 data sources, representing several research designs and 5 high-burden tumor types, were included for analyses. The percentages of races/ethnicities across each design/tumor type were compared with those of the 2017 US Census data. The authors used a framework based on the Belmont principles to evaluate the ethical strengths and/or weaknesses of each design.

Results: In all designs, white individuals were found to be overrepresented. African American and Asian individuals were underrepresented, and Native Americans had consistently poor or no representation. In general, ethical concerns varied according to the study design. Clinical trials were high with regard to respect for persons and beneficence but low for equitable subject selection related to the inclusion of race/ethnicity. Observational study designs were more inclusive for race/ethnicity compared with clinical and translational studies, but their clinical usefulness was less.

Conclusions: The authors proposed that ethical concerns should vary according to the study design. Because observational designs have strengths in inclusiveness for race/ethnicity, their clinical usefulness can be improved by extending the Learning Health System in hospital catchment populations, the use of health records linked to biospecimens, and minority oversampling. Likewise, minority enrollment into clinical trials can be improved through Learning Health System linking and by using National Cancer Institute-mandated Community Outreach and Engagement Cores. This will allow precision medicine for otherwise overlooked minority subgroups.

Keywords: cancer health disparities; race/ethnicity; research design; research ethics.

PubMed Disclaimer

Conflict of interest statement

There are no conflict of interest disclosures from any authors.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zonderman AB, Ejiogu N, Norbeck J, Evans MK. The influence of health disparities on targeting cancer prevention efforts. Am J Prev Med 2014;46(3 SUPPL. 1). doi:10.1016/j.amepre.2013.10.026 - DOI - PMC - PubMed
    1. Polite BN, Adams-Campbell LL, Brawley OW, et al. Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol 2017;67(5):JCO.2017.73.654. doi:10.1200/JCO.2017.73.6546 - DOI - PubMed
    1. NCI. National and State Cancer Registries. Division of Cancer Control and Population Sciences: Epidemiology and Genomics Research Program https://epi.grants.cancer.gov/registries.html#state. Published 2019.
    1. Smith CJ, Minas TZ, Ambs S. Analysis of Tumor Biology to Advance Cancer Health Disparity Research. Am J Pathol 2018;188(2):304–316. doi:10.1016/j.ajpath.2017.06.019 - DOI - PMC - PubMed
    1. Unger JM, Cook E, Tai E, Bleyer A. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. Am Soc Clin Oncol Educ B 2016;(36):185–198. doi:10.14694/EDBK_156686 - DOI - PMC - PubMed

Publication types